Holocene Advisors’s CG Oncology CGON Stock Holding History

Holocene Advisors’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-766,625	Closed	-$33.7M	–	717
2024 Q1	$33.7M	Buy	+766,625	New	+$31.3M	0.12%	182

Other funds holding CGON

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Holocene Advisors's CGON Position: Q2 2024 in Review

Holocene Advisors sold out of CG Oncology (CGON) in Q2 2024, closing a stake of 766,625 shares — an estimated $33.7M sold.

Holocene Advisors first reported a position in CGON in Q1 2024 and held it in 1 quarter. The position peaked at $33.7M in Q1 2024. 111 funds tracked by Wall St. Rank hold CGON as of Q2 2024.

Holocene Advisors reported no remaining CG Oncology position as of Q2 2024 after selling out during the quarter.
Holocene Advisors sold 766,625 CG Oncology shares in Q2 2024, an estimated $33.7M.
Holocene Advisors first reported a position in CG Oncology in Q1 2024 and held it in 1 quarter.
Holocene Advisors's CG Oncology position peaked at $33.7M in Q1 2024.
111 funds tracked by Wall St. Rank held CG Oncology as of Q2 2024.

Based on Holocene Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.